BRAX — Braxia Scientific Balance Sheet
0.000.00%
Last trade - 00:00- CA$1.32m
- CA$1.83m
- CA$1.88m
Annual balance sheet for Braxia Scientific, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2019 September 30th | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 0.856 | 11.1 | 8.68 | 1.46 |
| Net Total Receivables | — | 0.113 | 0.811 | 0.409 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Current Assets | 1.04 | 11.4 | 9.66 | 2.16 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | — | 0.05 | 0.168 | 0.82 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Total Assets | 1.16 | 18.5 | 11.6 | 3.88 |
| Accounts Payable | ||||
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 0.053 | 2.55 | 2.54 | 2.15 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Liabilities | 0.053 | 2.6 | 2.67 | 2.28 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1.11 | 15.9 | 8.96 | 1.6 |
| Total Liabilities & Shareholders' Equity | 1.16 | 18.5 | 11.6 | 3.88 |
| Total Common Shares Outstanding |